GlassScriptPhysician profile
Jerilee Emma Lomas
NPI 1093889529
$6,624.83
in general payments reported to CMS, 2019-2025
39 companies · $599 in 2025
The $599 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,107 · 2020: $706 · 2021: $863 · 2022: $1,095 · 2023: $1,064 · 2024: $1,190 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,853.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,349.63 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $1,219.07 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $593.48 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $421.98 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $370.49 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $340.18 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $284.28 | 2019-2025 | |
| Abbott Laboratories | $219.55 | 2020-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Amgen INC. | $212.14 | 2019-2025 | Repatha, Otezla, Evenity |
| Boston Scientific Corporation | $160.85 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $152.75 | 2019-2024 | Xarelto |
| Dexcom, INC. | $141.68 | 2022-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $135.76 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $102.00 | 2025 | Caplyta |
| Astellas Pharma US INC | $82.29 | 2024-2025 | Veozah |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerilee Lomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.